Clinical-trial data on retatrutide shows major weight loss and surprising improvements beyond the scale.

The state tops Business Insider's degree ranking with 22.6% advanced degrees, then cashes in via a high-earning, education-heavy economy.

A new WWII submarine movie found legs at home, cracking the domestic top 10 and outgrossing Das Boot there.

The first serious stumble after a two-month rally: what Friday’s Nasdaq crash signals for portfolio risk and market planning.

He runs a biweekly “Dario Vision Quest” all-hands to keep 2,500 employees aligned as the AI race heats up.

Inside Intel’s cleanroom, R&D, and packaging operations, we see what Washington is trying to secure as China tensions rise.

A £1.25bn build faces delay risk, forcing planners, investors, and customers to rerun timing assumptions fast.

Harry's and Coterie owner Mammoth Brands is aiming higher after disrupting razors, diapers, and deodorant.

A podcast protégé is borrowing the Diary of a CEO playbook, but tailoring it for women and a different brand of “research.”

An Airbnb host sues Kyle Vogt’s $2 billion robotics startup, alleging false guest bookings in April.

The question is not if, but when. Policy analysts say Chinese drug outlicensing may turn into branded global sales by 10 to 15 years.

UK’s maritime regulator helps shape the first global safety code for autonomous ships, paving mandatory rules by 2032.